OBJECTIVE -Glucagon-like peptide (GLP)-1 receptor is encoded by GLP1R. The effect of genetic variation at this locus on the response to GLP-1 is unknown. This study assessed the effect of GLP1R polymorphisms on insulin secretion in response to hyperglycemia and to infused GLP-1 in nondiabetic subjects.
xpression of a nonsynonymous single nucleotide polymorphism (SNP), which results in substitution of methionine for threonine at position 149 of GLP1R in cell systems, decreases binding affinity for glucagon-like peptide (GLP)-1 and intracellular signaling after hormonereceptor binding (1) . These functional effects suggest that genetic variation in GLP1R may alter responsiveness to GLP-1 in vivo. To examine this hypothesis, we used a hyperglycemic clamp, together with GLP-1-amide (7, 36) infusion, and measured insulin secretion using a modification of the C-peptide minimal model to determine ␤-cell responsivity (⌽ Total ) to GLP-1 in vivo.
RESEARCH DESIGN AND METHODS -After approval from the Mayo Institutional Review Board, 88 healthy, nondiabetic subjects gave informed written consent to participate (online appendix, available at http://care. diabetesjournals.org/cgi/content/full/dc10-0200/DC1). The study was registered at www.clinicaltrials.gov (NCT00588380).
After an overnight fast, at 0700 (0 min) a primed (0.1 g/kg over 4 min), continuous infusion of 50% dextrose maintained peripheral glucose concentrations at ϳ8.5 mmol/l. At 0900 (120 min), GLP-1-amide (7,36) (Bachem, San Diego, CA) was infused (1.5 pmol/kg over 10 min, subsequently 0.75 pmol/kg/min). At 1000 (180 min), the infusion rate was increased to 1.5 pmol/kg/min.
Measurement of insulin secretion: C-peptide minimal model
The model used to describe ␤-cell secretion is a modification of the C-peptide minimal model that assumes a nonlinear and derivative action of GLP-1 on both the static (⌽ s ) and dynamic (⌽ d ) components of total insulin secretion (⌽ Total ) (2,3).
Selection and genotyping of tag SNPs for GLP1R
Twenty-one tag SNPs were genotyped (online appendix).
Statistical analysis
All data are presented as means Ϯ SEM. Using the Kruskal-Wallis (general allelic model), we assessed univariate associations of genotype with ⌽ Total in the presence of either glucose alone (mean values at 110 -120 min), or glucose and 0.75 pmol/kg/min GLP-1 (170 -180 min), or glucose and 1.5 pmol/kg/min GLP-1 (230 -240 min), and with peak values of ⌽ Total observed in the presence of GLP-1. If the P value for the overall univariate test of association was Ͻ0.1, then the associations for specific genotype pairs (e.g., 1,1 vs. 1,2 or 2,2 vs. 1,1) were also examined using a Mann-Whitney rank sum test. The SAS package was used for analyses, and a P value Ͻ0.05 was considered to be statistically significant. 
RESULTS
Effect of rs6923761 and rs3765467 genotype on ␤-cell responsivity Fig. 1A shows univariate association of rs6923761 genotype with ⌽ Total assuming a general genetic model. At 120 min, in the presence of glucose alone, no significant associations with ⌽ Total were detected (34 Ϯ
When the effect of rs6923761 genotype on ⌽ Total was examined (Fig. 1B ) using a recessive model (i.e., 1,1 vs. individuals with one or more copies of the minor allele), the associations at 240 min (152 Ϯ 12 vs. 127 Ϯ 11 min
Ϫ1
, P ϭ 0.03) and at peak ⌽ Total (160 Ϯ 12 vs. 136 Ϯ 12 min
, P ϭ 0.03) were nominally significant. Differences in ⌽ Total at 180 min (104 Ϯ 9 vs. 90 Ϯ 8) were not significant (P ϭ 0.09).
The three heterozygotes for the minor allele of rs3765467 (Fig. 1C) , P ϭ 0.005). An ANCOVA adjusting for sex, BMI, and fasting glucose strengthened the association of rs3765467 with peak and 240 min ⌽ Total (P ϭ 0.0021, P ϭ 0.0026, respectively). None of the reported P values were corrected for multiple testing; applying a BenjaminiHochberg approach to correct for 21 SNPs and 3 measurements, a P value of Ͻ0.0024 would be significant (4).
CONCLUSIONS -I n t h i s p i l o t study, we show that in the presence of hyperglycemia, two nonsynonymous SNPs in GLP1R are nominally associated with altered insulin secretory response to infused GLP-1. One of these nonsynonymous SNPs, rs6923761 (which has a minor allele frequency of ϳ29% in Caucasians), results in the substitution of serine for glycine at position 168 and may decrease responsiveness to infused GLP-1. Homozygotes for the major allele of rs6923761 exhibited a ϳ15% increase 
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care.diabetesjournals.org DIABETES CARE, VOLUME 33, NUMBER 9, SEPTEMBER 2010in mean ⌽ Total compared with heterozygotes or homozygotes for the minor allele. The other nonsynonymous SNP, rs3765467, results in substitution of glutamine for arginine at position 131. Heterozygotes for the minor allele of rs3765467 exhibited Ͼ100% increase in ⌽ Total compared with homozygotes for the major allele. However, the observed increase in ⌽ Total in response to hyperglycemia alone suggests that these observations may not be solely due to altered responsiveness to endogenous GLP-1.
The actions of GLP-1 (primarily stimulation of insulin secretion and suppression of glucagon secretion) are mediated by binding to its cognate receptor. Exenatide, a GLP-1 receptor agonist, binds to the GLP-1 receptor with greater affinity than its natural ligand due to a nine amino-acid COOH-terminal sequence that is absent in native GLP-1 (5). Substitution of glycine for alanine at position eight of native GLP-1 decreases affinity for the receptor (6), suggesting that both N-and COOH-terminal ends of GLP-1 bind the receptor.
A consequence of the constant glucose concentrations during the experiment was that ⌽ d was a small component of ⌽ Total ; prior studies have suggested that incretins alter both static and dynamic components of ␤-cell responses (7, 8) . GLP-1 also inhibits gastrointestinal motility and may alter glucose delivery to the small intestine (9) . By design, our experiment could not test for any potential effects of variation in GLP1R on these parameters. At present, variation in GLP1R has not been associated with type 2 diabetes (10); together with the data in our study, this suggests that genetic differences in GLP-1 responsiveness attributable to variation in GLP1R likely occurs at supraphysiologic GLP-1 concentrations. Given the exploratory nature of this experiment, the results should be interpreted cautiously prior to replication in other cohorts with an increased frequency of the minor allele of rs3765467.
